<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">53868</article-id><article-id pub-id-type="doi">10.7554/eLife.53868</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>RNA-guided retargeting of <italic>Sleeping Beauty</italic> transposition in human cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-166441"><name><surname>Kovač</surname><given-names>Adrian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166442"><name><surname>Miskey</surname><given-names>Csaba</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166443"><name><surname>Menzel</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166444"><name><surname>Grueso</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166445"><name><surname>Gogol-Döring</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-95856"><name><surname>Ivics</surname><given-names>Zoltan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7803-6658</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Medical Biotechnology</institution>, <institution>Paul Ehrlich Institute</institution>, <addr-line><named-content content-type="city">Langen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Bioinformatics</institution>, <institution>University of Applied Sciences</institution>, <addr-line><named-content content-type="city">Giessen</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-166221"><name><surname>Essner</surname><given-names>Jeffrey</given-names></name><role>Reviewing editor</role><aff><institution>Iowa State University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zoltan.ivics@pei.de</email> (ZI);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>06</day><month>03</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e53868</elocation-id><history><date date-type="received"><day>22</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>05</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Kovač et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kovač et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-53868-v1.pdf"/><abstract><p>An ideal tool for gene therapy would enable efficient gene integration at predetermined sites in the human genome. Here we demonstrate biased genome-wide integration of the <italic>Sleeping Beauty</italic> (SB) transposon by combining it with components of the CRISPR/Cas9 system. We provide proof-of-concept that it is possible to influence the target site selection of SB by fusing it to a catalytically inactive Cas9 (dCas9) and by providing a single guide RNA (sgRNA) against the human <italic>Alu</italic> retrotransposon. Enrichment of transposon integrations was dependent on the sgRNA, and occurred in an asymmetric pattern with a bias towards sites in a relatively narrow, 300-bp window downstream of the sgRNA targets. Our data indicate that the targeting mechanism specified by CRISPR/Cas9 forces integration into genomic regions that are otherwise poor targets for SB transposition. Future modifications of this technology may allow the development of methods for specific gene insertion for precision genetic engineering.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><funding-statement>No external funding was received for this work.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Zoltan Ivics, Patent applications around targeted transposon integration technology(Patent Nos. EP1594971B1,  EP1594972B1 and EP1594973B1)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>DNA sequence data generated and analysed during this study are included in the manuscript and Source Data Files 1-4.</p></sec><supplementary-material><ext-link xlink:href="elife-53868-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>